Lipopolysaccharide signals an endothelial apoptosis pathway through TNF receptor-associated factor 6-mediated activation of c-Jun NH2-terminal kinase

Journal of Immunology

Volumn 169, Issue 5, 2002, Pages 2611-2618

  Hull, Christopher ^a   McLean, Graeme ^a   Wong, Fred ^a   Duriez, Patrick J ^a   Karsan, Aly ^a  

^a BRITISH COLUMBIA CANCER RESEARCH CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOPOLYSACCHARIDE; STRESS ACTIVATED PROTEIN KINASE; SYNAPTOPHYSIN; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR RECEPTOR; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 6; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL PROTECTION; CELL SURVIVAL; ENDOTHELIUM INJURY; ENZYME ACTIVATION; ENZYME INHIBITION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

EID: 0036721696     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.169.5.2611     Document Type: Article

References (69)

1. Role of endotoxin and host cytokines in septic shock
2. Lipopolysaccharide induces disseminated endothelial apoptosis requiring ceramide generation
3. Human endothelial cell response to lipopolysaccharide, interleukin-1, and tumor necrosis factor is regulated by protein synthesis
4. Lipopolysaccharide induces the antiapoptotic molecules, A1 and A20, in microvascular endothelial cells
5. Lipopolysaccharide mediates endothelial apoptosis by a FADD-dependent pathway
6. Endothelial cell death induced by tumor necrosis factor a is inhibited by the Bcl-2 family member, A1
7. Toll-like receptor-2 mediates lipopolysaccharide-induced cellular signalling
8. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: Mutations in Tlr4 gene
9. Toll-like receptors as adjuvant receptors
10. MD-2, a molecule that confers lipopolysaccharide responsiveness on Toll-like receptor 4
11. The Toll-like receptor protein RP105 regulates lipopolysaccharide signaling in B cells
12. MyD88 is an adaptor protein in the hToll/IL-1 receptor family signaling pathways
13. TRAF6 is a signal transducer for interleukin-1
14. IRAK (Pelle) family member IRAK-2 and MyD88 as proximal mediators of IL-1 signaling
15. IRAK-M is a novel member of the Pelle/interleukin-1 receptor-associated kinase (IRAK) family
16. Bacterial lipopolysaccharide activates nuclear factor-κB through interleukin-1 signaling mediators in cultured human dermal endothelial cells and mononuclear phagocytes
17. TRAF6 deficiency results in osteopetrosis and defective interleukin-1, CD40, and LPS signaling
18. The human Toll signaling pathway: Divergence of nuclear factor κB and JNK/SAPK activation upstream of tumor necrosis factor receptor-associated factor 6 (TRAF6)
19. Characterization of the roles of TNF receptor-associated factor 6 in CD40-mediated B lymphocyte effector functions
20. Activation of NF-κB by RANK requires tumor necrosis factor receptor-associated factor (TRAF) 6 and NF-κB-inducing kinase: Identification of a novel TRAF6 interaction motif
21. The apoptotic signaling pathway activated by Toll-like receptor-2
22. The biochemistry of apoptosis
23. Regulation of c-Myc through phosphorylation at Ser-62 and Ser-71 by c-Jun N-terminal kinase
24. Signal-induced site-specific phosphorylation targets IκBα to the ubiquitin-proteasome pathway
25. A1 functions at the mitochondria to delay endothelial apoptosis in response to tumor necrosis factor
26. Identification of an oncoprotein- and UV-responsive protein kinase that binds and potentiates the c-Jun activation domain
27. An essential role for NF-κB in preventing TNF-α-induced cell death
28. Suppression of TNF-α-induced apoptosis by NF-κB
29. TNF- and cancer therapyinduced apoptosis: Potentiation by inhibition of NF-κB
30. Activation and injury of endothelial cells by cytokines
31. NF-κB activation is required for human endothelial cell survival during exposure to tumor necrosis factor-α but not to interleukin-1β or lipopolysaccharide
32. IκBα is essential for maintaining basal c-Jun N-terminal kinase (JNK) activation and regulating JNK-mediated resistance to tumor necrosis factor cytotoxicity in L929 cells
33. Daxx, a novel Fas-binding protein that activates JNK and apoptosis
34. Activation of the c-Jun N-terminal kinase/stress-activated protein kinase pathway by overexpression of caspase-8 and its homologs
35. Inhibition of c-Jun N-terminal kinase by overexpression of the JNK binding domain of JIP-1 prevents apoptosis in sympathetic neurons
36. Diverse functions of JNK signaling and c-Jun in stress response and apoptosis
37. Signal transduction by the c-Jun N-terminal kinase (JNK): From inflammation to development
38. The activation of the c-Jun N-terminal kinase and p38 mitogen-activated protein kinase signaling pathways protects HeLa cells from apoptosis following photodynamic therapy with hypericin
39. Nuclear factor κB-independent cytoprotective pathways originating at tumor necrosis factor receptor-associated factor 2
40. Requirement of JNK for stress-induced activation of the cytochrome c-mediated death pathway
41. L in response to DNA damage
42. Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade
43. Inhibition of human caspases by peptide-based and macromolecular inhibitors
44. JNK and p38 are activated by erythropoietin (EPO) but are not induced in apoptosis following EPO withdrawal in EPO-dependent HCD57 cells
45. Correlation between sustained c-Jun N-terminal protein kinase activation and apoptosis induced by tumor necrosis factor-α in rat mesangial cells
46. 2-terminal kinase (JNK) via caspase-dependent and caspase-independent pathways
47. Fas induces cytoplasmic apoptotic responses and activation of the MKK7-JNK/SAPK and MKK6-p38 pathways independent of CPP32-like proteases
48. The sepsis syndrome: Definition and general approach to management
49. Acute inflammation and microthrombosis induced by endotoxin, interleukin-1, and tumor necrosis factor and their implication in Gram-negative infection
50. Endotoxins and disease mechanisms
51. Endothelial dysfunction in a rat model of endotoxic shock: Importance of the activation of poly(ADP-ribose) synthetase by peroxynitrite
52. Does programmed cell death (apoptosis) play a role in the development of multiple organ dysfunction in critically ill patients? A review and a theoretical framework
53. Tumor necrosis factor-α and lipopolysaccharide induce apoptotic cell death in bovine glomerular endothelial cells
54. Nitric oxide inhibits lipopolysaccharide-induced apoptosis in pulmonary artery endothelial cells
55. Collagen is a survival factor against LPS-induced apoptosis in cultured sheep pulmonary artery endothelial cells
56. Bacterial lipopolysaccharide disrupts endothelial monolayer integrity and survival signaling events through caspase cleavage of adherens junction proteins
57. Direct effects of endotoxin on the endothelium: Barrier function and injury
58. Critical involvement of transmembrane tumor necrosis factor-α in endothelial programmed cell death mediated by ionizing radiation and bacterial endotoxin
59. Age related decline in cytokine induced nitric oxide synthase activation and apoptosis in cultured endothelial cells: Minimal involvement of nitric oxide in the apoptosis
60. Nuclear factor (NF)-κB-regulated X-chromosome-linked iap gene expression protects endothelial cells from tumor necrosis factor α-induced apoptosis
61. Tumor necrosis factor receptor-associated factor (TRAF) family: Adapter proteins that mediate cytokine signaling
62. Signal transduction pathways activated by the IL-1 receptor family: Ancient signaling machinery in mammals, insects, and plants
63. Requirement of tumor necrosis factor receptor-associated factor (TRAF)6 in interleukin 17 signal transduction
64. The death domain kinase RIP mediates the TNF-induced NF-κB signal
65. Early lethality, functional NF-κB activation, and increased sensitivity to TNF-induced cell death in TRAF2-deficient mice
66. Stimulus-dependent synergism of the antiapoptotic tumor necrosis factor receptor-associated factor 2 (TRAF2) and nuclear factor κB pathways
67. Tumor necrosis factor receptor-associated factor 6 (TRAF6) deficiency results in exencephaly and is required for apoptosis within the developing CNS
68. Bcl-2 undergoes phosphorylation by c-Jun N-terminal kinase/stress-activated protein kinases in the presence of the constitutively active GTP-binding protein Racl
69. 2-terminal kinase activation leads to a FADD-dependent but Fas ligand-independent cell death in Jurkat T cells